Similar articles for PMID: 16496035

Year	Number of Results
1997	1
1999	1
2001	1
2002	3
2003	2
2004	6
2005	5
2006	12
2007	7
2008	3
2009	8
2010	3
2011	3
2012	6
2013	10
2014	6
2015	4
2016	4
2017	6
2018	6
2019	6
2020	7
2021	5
2022	1
2024	0

1

Efficacy of methylphenidate in children with attention-deficit hyperactivity disorder and learning disabilities: a randomized crossover trial.

Grizenko N, Bhat M, Schwartz G, Ter-Stepanian M, Joober R. Grizenko N, et al. J Psychiatry Neurosci. 2006 Jan;31(1):46-51. J Psychiatry Neurosci. 2006. PMID: 16496035 Free PMC article. Clinical Trial.

2

A Randomized, Double-Blind, Placebo-Controlled, Two-Way Crossover Clinical Trial of ORADUR-Methylphenidate for Treating Children and Adolescents with Attention-Deficit/Hyperactivity Disorder.

Huang YS, Yeh CB, Chen CH, Shang CY, Gau SS. Huang YS, et al. J Child Adolesc Psychopharmacol. 2021 Apr;31(3):164-178. doi: 10.1089/cap.2020.0104. Epub 2020 Dec 31. J Child Adolesc Psychopharmacol. 2021. PMID: 33395356 Free PMC article. Clinical Trial.

3

Randomized, Double-Blind, Placebo-Controlled Acute Comparator Trials of Lisdexamfetamine and Extended-Release Methylphenidate in Adolescents With Attention-Deficit/Hyperactivity Disorder.

Newcorn JH, Nagy P, Childress AC, Frick G, Yan B, Pliszka S. Newcorn JH, et al. CNS Drugs. 2017 Nov;31(11):999-1014. doi: 10.1007/s40263-017-0468-2. CNS Drugs. 2017. PMID: 28980198 Free PMC article.

4

Methylphenidate treatment of attention deficit hyperactivity disorder in young people with learning disability and difficult-to-treat epilepsy: evidence of clinical benefit.

Fosi T, Lax-Pericall MT, Scott RC, Neville BG, Aylett SE. Fosi T, et al. Epilepsia. 2013 Dec;54(12):2071-81. doi: 10.1111/epi.12399. Epilepsia. 2013. PMID: 24304474 Free PMC article. Review.

5

Effects of methylphenidate on acute math performance in children with attention-deficit hyperactivity disorder.

Grizenko N, Cai E, Jolicoeur C, Ter-Stepanian M, Joober R. Grizenko N, et al. Can J Psychiatry. 2013 Nov;58(11):632-9. doi: 10.1177/070674371305801109. Can J Psychiatry. 2013. PMID: 24246434 Clinical Trial.

6

Methylphenidate hydrochloride modified-release in adults with attention deficit hyperactivity disorder: a randomized double-blind placebo-controlled trial.

Huss M, Ginsberg Y, Tvedten T, Arngrim T, Philipsen A, Carter K, Chen CW, Kumar V. Huss M, et al. Adv Ther. 2014 Jan;31(1):44-65. doi: 10.1007/s12325-013-0085-5. Epub 2013 Dec 27. Adv Ther. 2014. PMID: 24371021 Free PMC article. Clinical Trial.

7

Effects of Extended-Release Methylphenidate Treatment on Cognitive Task Performance in Children with Autism Spectrum Disorder and Attention-Deficit/Hyperactivity Disorder.

Pearson DA, Santos CW, Aman MG, Arnold LE, Lane DM, Loveland KA, Mansour R, Ward AR, Casat CD, Jerger S, Schachar RJ, Bukstein OG, Cleveland LA. Pearson DA, et al. J Child Adolesc Psychopharmacol. 2020 Sep;30(7):414-426. doi: 10.1089/cap.2020.0004. Epub 2020 Jul 9. J Child Adolesc Psychopharmacol. 2020. PMID: 32644833 Free PMC article.

8

Academic, behavioral, and cognitive effects of OROS® methylphenidate on older children with attention-deficit/hyperactivity disorder.

Wigal SB, Wigal T, Schuck S, Brams M, Williamson D, Armstrong RB, Starr HL. Wigal SB, et al. J Child Adolesc Psychopharmacol. 2011 Apr;21(2):121-31. doi: 10.1089/cap.2010.0047. Epub 2011 Apr 13. J Child Adolesc Psychopharmacol. 2011. PMID: 21488750 Free PMC article. Clinical Trial.

9

A randomised, placebo-controlled, 24-week, study of low-dose extended-release methylphenidate in adults with attention-deficit/hyperactivity disorder.

Rösler M, Fischer R, Ammer R, Ose C, Retz W. Rösler M, et al. Eur Arch Psychiatry Clin Neurosci. 2009 Mar;259(2):120-9. doi: 10.1007/s00406-008-0845-4. Epub 2009 Jan 22. Eur Arch Psychiatry Clin Neurosci. 2009. PMID: 19165529 Clinical Trial.

10

A post hoc comparison of the effects of lisdexamfetamine dimesylate and osmotic-release oral system methylphenidate on symptoms of attention-deficit hyperactivity disorder in children and adolescents.

Soutullo C, Banaschewski T, Lecendreux M, Johnson M, Zuddas A, Anderson C, Civil R, Higgins N, Bloomfield R, Squires LA, Coghill DR. Soutullo C, et al. CNS Drugs. 2013 Sep;27(9):743-51. doi: 10.1007/s40263-013-0086-6. CNS Drugs. 2013. PMID: 23801529 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

101 results

Results by year